1. Targeted Deep Sequencing of Peripheral CD34+ Cells can Reproduce Bone Marrow Molecular Profile in MDS Patients. (April 2017) Authors: Acha, P.; Martin, R.; Palomo, L.; Ganster, C.; Dierks, S.; Mallo, M.; Ademà, V.; Fuster-Tormo, F.; Gómez-Marzo, P.; De Haro, N.; Jiménez-García, F.; Solanes, N.; Zamora, L.; Xicoy, B.; Kominowski, A.; Stromburg, M.; Brockmann, A.; Truemper, L.; Sole, F.; Haase, D. Journal: Leukemia research Issue: Volume 55(2017)Supplement 1 Page Start: S154 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. FIRST‐LINE THERAPY OF T‐CELL LYMPHOMA: ALLOGENEIC OR AUTOLOGOUS TRANSPLANTATION FOR CONSOLIDATION ‐ FINAL RESULTS OF THE AATT STUDY. (12th June 2019) Authors: Tournilhac, O.; Truemper, L.; Ziepert, M.; Bouabdallah, K.; Nickelsen, M.; Maury, S.; Reimer, P.; Jaccard, A.; Herr, W.; Wilhelm, M.; Cartron, G.; Wulf, G.; Sanhes, L.; Dreger, P.; Lamy, T.; Kroschinsky, F.; Lindemann, H.; Roussel, M.; Viardot, A.; Sibon, D. Journal: Hematological oncology Issue: Volume 37(2019)Supplement 2 Page Start: 99 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. RADIOTHERAPY TO BULKY DISEASE PET‐NEGATIVE AFTER IMMUNOCHEMOTHERAPY CAN BE SPARED IN ELDERLY DLBCL PATIENTS: RESULTS OF a PLANNED INTERIM ANALYSIS OF THE FIRST 187 PATIENTS WITH BULKY DISEASE TREATED IN THE OPTIMAL > 60 STUDY OF THE DSHNHL. (June 2017) Authors: Pfreundschuh, M.; Christofyllakis, K.; Altmann, B.; Ziepert, M.; Haenel, M.; Viardot, A.; Neubauer, A.; Held, G.; Truemper, L.; Dreyling, M.; Kanz, L.; Hallek, M.; Schmitz, N.; Heintges, T.; Kölbel, C.; Buecker, A.; Ruebe, C.; Hellwig, D.; Berdel, C.; Poeschel, V. Journal: Hematological oncology Issue: Volume 35(2017)Supplement 2 Page Start: 129 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Radioimmunotherapy for follicular lymphoma achieves excellent lymphoma control in first line and relapse: 8‐year follow‐up data of 281 patients from the international RIT‐registry. (June 2017) Authors: Hohloch, K.; Scholz, C.; Windemuth‐Kiesselbach, C.; Kolz, J.; Zinzani, P.L.; Cacchione, R.; Woijciech Jurczak, W.; Bischof‐Delalaoye, A.; Truemper, L. Journal: Hematological oncology Issue: Volume 35(2017)Supplement 2 Page Start: 361 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. ANTI‐INFECTIVE PROPHYLAXIS WITH ACICLOVIR AND COTRIMOXAZOLE SIGNIFICANTLY REDUCES THE RATE OF INFECTIONS AND THERAPY‐ASSOCIATED DEATHS IN ELDERLY PATIENTS WITH DLBCL UNDERGOING R‐CHOP IMMUNOCHEMOTHERAPY. (June 2017) Authors: Murawski, N.; Amam, J.; Altmann, B.; Ziepert, M.; Haenel, M.; Viardot, A.; Neubauer, A.; Held, G.; Truemper, L.; Dreyling, M.; Kanz, L.; Hallek, M.; Schmitz, N.; Heintges, T.; Koelbel, C.; Poeschel, V.; Pfreundschuh, M. Journal: Hematological oncology Issue: Volume 35(2017)Supplement 2 Page Start: 200 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗